The use of artificial intelligence in pharmacovigilance: a systematic review of the literature

M Salas, J Petracek, P Yalamanchili, O Aimer… - Pharmaceutical …, 2022 - Springer
Introduction Artificial intelligence through machine learning uses algorithms and prior
learnings to make predictions. Recently, there has been interest to include more artificial …

The coming of age of AI/ML in drug discovery, development, clinical testing, and manufacturing: The FDA Perspectives

SK Niazi - Drug Design, Development and Therapy, 2023 - Taylor & Francis
Artificial intelligence (AI) and machine learning (ML) represent significant advancements in
computing, building on technologies that humanity has developed over millions of years …

Trustworthy AI for safe medicines

JU Stegmann, R Littlebury, M Trengove… - Nature Reviews Drug …, 2023 - nature.com
The pharmaceutical industry is rapidly adopting new and evolving applications of artificial
intelligence (AI), and so we concur with the point made by Hines et al.(Nat. Rev. Drug …

Digital technology applications in the management of adverse drug reactions: bibliometric analysis

O Litvinova, AWK Yeung, FP Hammerle, ME Mickael… - Pharmaceuticals, 2024 - mdpi.com
Adverse drug reactions continue to be not only one of the most urgent problems in clinical
medicine, but also a social problem. The aim of this study was a bibliometric analysis of the …

An industry perspective on the use of machine learning in drug and vaccine safety

JL Painter, R Kassekert, A Bate - Frontiers in Drug Safety and …, 2023 - frontiersin.org
In recent years there has been growing interest in the use of machine learning across the
pharmacovigilance lifecycle to enhance safety monitoring of drugs and vaccines. Here we …

Adopting artificial intelligence in ITIL for information security management—way forward in industry 4.0

M Rajagopal, S Ramkumar - Artificial Intelligence and Cyber Security in …, 2023 - Springer
To help prevent, detect, and resolve security-related problems within a company, AI must be
deployed. Industry 4.0 hopes to significantly improve information security by bringing forth …

[PDF][PDF] Artificial intelligence in pharmacovigilance: a regulatory perspective on explainability

LC Pinheiro, X Kurz - Pharmacoepidemiol Drug Saf, 2022 - researchgate.net
Artificial intelligence (AI) holds the promise of boosting efficiency of processes and
increasing insights into data across all aspects of life, including healthcare, such as for …

A science-based methodology framework for the assessment of combination safety risks in clinical trials

AC Patera, J Maidment, B Maroj, A Mohamed… - Pharmaceutical …, 2023 - Springer
Multiple components factor into the assessment of combination safety risks when two or
more novel individual products are used in combination in clinical trials. These include, but …

[HTML][HTML] Новые технологии в электронных системах по фармаконадзору для держателей регистрационных удостоверений

ОА Логиновская, ВП Колбатов, РВ Сухов… - Безопасность и риск …, 2022 - cyberleninka.ru
В связи с появлением новых путей получения информации о безопасности
лекарственных средств актуальным становится внедрение современных …

Provision and Characterization of a Corpus for Pharmaceutical, Biomedical Named Entity Recognition for Pharmacovigilance: Evaluation of Language Registers and …

J Dietrich, P Kazzer - Drug Safety, 2023 - Springer
Abstract Introduction and Objective Machine learning (ML) systems are widely used for
automatic entity recognition in pharmacovigilance. Publicly available datasets do not allow …